Hanlin Gao - Oct 30, 2022 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
Chief Scientific Officer
Signature
/s/ Paul Kim as Attorney-in-Fact
Stock symbol
FLGT
Transactions as of
Oct 30, 2022
Transactions value $
-$3,061
Form type
4
Date filed
11/1/2022, 05:06 PM
Previous filing
Aug 19, 2022
Next filing
Nov 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Tax liability -$3.06K -76 -0.01% $40.28 855K Oct 30, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021.